发明名称 HETEROCYCLIC-CONDENSED PYRIDINES
摘要 PROBLEM TO BE SOLVED: To obtain the subject compound useful for treatment and prevention of heterolipidemia or atherosclerosis. SOLUTION: This compound is expressed by formula I [A is an 6-10C aryl; D is formula II or III (R<5> and R<6> are each a 3-8C cycloalkyl; X is an alkylene of 8C or less and the like; R<7> is H and a halogen; R<8> is H, a halogen, an azide, etc.); E is a 3-8C cycloalkyl and the like; R<1> and R<2> are combined to form an 6C alkylene chain], its salt and the N-oxide, e.g. 3-ethyl 5-methyl 6- cyclopentyl-4-(4-fluorophenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-di carboxylate. The compound is obtained by initially introducing the substituent D into the compound of formula IV by Grignard reaction or Wittig reaction using organic metal reagents in an inactive solvent followed by suitably converting or introducing substituents illustrated as A, E and/or R<1> and R<2> by ordinary processes.
申请公布号 JPH10167967(A) 申请公布日期 1998.06.23
申请号 JP19970192014 申请日期 1997.07.03
申请人 BAYER AG 发明人 SCHMECK CARSTEN DR;MUELLER-GLIEMANN MATTHIAS DR;SCHMIDT GUNTER DR;BRANDES ARNDT DR;RORUFU ANGAABAUAA;LOEGERS MICHAEL DR;BREMM KLAUS-DIETER DR;BISCHOFF HILMAR DR;SCHMIDT DELF DR;SCHUHMACHER JOACHIM DR
分类号 C07D491/044;A61K31/435;A61K31/44;A61K31/4418;A61K31/445;A61K31/451;A61K31/55;A61P3/06;A61P9/10;C07C229/14;C07D211/86;C07D211/90;C07D213/80;C07D401/04;C07D471/04;C07D491/04;C07D491/20;C07D493/14;C07D495/04;C07F7/18 主分类号 C07D491/044
代理机构 代理人
主权项
地址